Overactive Bladder

Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder. October 15, 2018

Risk of psychiatric disorders in overactive bladder syndrome: a nationwide cohort study in Taiwan. October 13, 2018

Use of Ultrasound Urodynamics to Identify Differences in Bladder Shape Between Individuals With and Without Overactive Bladder. October 13, 2018

The Association Between Overactive Bladder and Falls and Fractures: A Systematic Review. October 13, 2018

Predictors of Nerve Stimulator Success in Patients With Overactive Bladder. October 6, 2018

Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron. October 6, 2018

Occupation and lower urinary tract symptoms in women: A rapid review and meta-analysis from the PLUS research consortium. October 6, 2018

OnabotulinumtoxinA injections in men with refractory idiopathic detrusor overactivity. October 6, 2018

6-month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder. September 24, 2018

Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study. September 24, 2018

Recurrent Urinary Tract Infections in Females and the Overlap with Overactive Bladder. September 24, 2018

Can Intradetrusor OnabotulinumtoxinA Injections Alter Heart Function in Patients with Cardiac Arrhythmia? September 15, 2018

Management of Overactive Bladder in Older Women. September 15, 2018

The development of a patient-reported outcome measure for real-time symptom assessment in a population with functional urologic complaints-A focus group study. September 15, 2018

A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain. September 15, 2018

[Contribution of pharmacological research to the discovery of a first-in-class drug, mirabegron, for the treatment of overactive bladder]. September 10, 2018

Mirabegron escalation to 50 mg further improves daily urgency and urgency urinary incontinence in Asian patients with overactive bladder. September 10, 2018

What Is the Role of Additional Pharmacotherapy and Neuromodulation in Patients with Marginal Benefit from Botulinum Toxin Injection? September 10, 2018

Complications of Botox and their Management. September 10, 2018

Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017? September 2, 2018

Page 1 of 75